MedPath

扬州艾迪制药有限公司

Ownership
-
Established
1998-11-11
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Powdered Bacillus Cereus

Product Name
蜡样芽胞杆菌粉
Approval Number
国药准字H32025793
Approval Date
Sep 9, 2020
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H32021029
Approval Date
Jan 22, 2016
NMPA

Gentamycin Sulfate Tablets

Product Name
硫酸庆大霉素片
Approval Number
国药准字H32021046
Approval Date
Jan 22, 2016
NMPA

Lincomycin Hydrochloride Capsules

Product Name
盐酸林可霉素胶囊
Approval Number
国药准字H32020724
Approval Date
Jan 22, 2016
NMPA

Lincmycin Hydrochloride Tablets

Product Name
盐酸林可霉素片
Approval Number
国药准字H32021034
Approval Date
Jan 22, 2016
NMPA

Lincomycin Hydrochloride Capsules

Product Name
盐酸林可霉素胶囊
Approval Number
国药准字H32020725
Approval Date
Jan 22, 2016
NMPA

Lincmycin Hydrochloride Tablets

Product Name
盐酸林可霉素片
Approval Number
国药准字H32021033
Approval Date
Jan 15, 2016
NMPA

Rifandine Capsules

Product Name
利福定胶囊
Approval Number
国药准字H32025419
Approval Date
Jan 15, 2016
NMPA

Cycloclenbuterol Hydrochloride Tablets

Product Name
盐酸环仑特罗片
Approval Number
国药准字H32025417
Approval Date
Jan 15, 2016
NMPA

Clotrimazole Tablets

Product Name
克霉唑片
Approval Number
国药准字H32020585
Approval Date
Jan 15, 2016
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.